{"0": ["genocea", "biosciences", "inc", "biopharmaceutical", "company", "discovers", "develops", "novel", "vaccines", "immunotherapies", "treat", "infectious", "diseases", "company", "uses", "proprietary", "discovery", "platform", "antigen", "lead", "acquisition", "system", "design", "vaccine", "view"], "1": ["founded", "cambridge", "mass", "genocea", "biosciences", "develops", "novel", "vaccine", "immunotherapy", "programs", "stimulate", "cell", "arm", "immune", "system"], "2": ["seeking", "experienced", "motivated", "elisa", "scientist", "join", "fast-growing", "company", "bioassay", "scientist", "responsible", "elisa", "method", "development", "execution", "complement", "clinical", "preclinical", "vaccine", "development", "teams", "seeking", "senior", "associate", "join", "analytical", "development", "formulations", "department", "cambridge", "ideal", "candidate", "motivated", "energetic", "detail-oriented", "person", "provide", "support", "analytical", "characterization", "formulation", "development", "protein", "antigens", "used", "vaccines"], "3": ["cutting", "edge", "technologies", "compelling", "solutions", "genocea", "proprietary", "technology", "platform", "atlas", "\u2122", "first", "kind", "enable", "comprehensive", "profiling", "cell", "responses", "hundreds", "humans", "exposed", "pathogen", "identify", "drivers", "cell", "response", "vaccines", "recognized", "cost-effective", "successful", "approach", "managing", "diseases", "yet", "traditional", "methods", "discovering", "developing", "vaccines", "slow", "insufficiently", "comprehensive", "meaningfully", "address", "complexity", "many", "pathogens", "learn"], "4": ["seeking", "experienced", "motivated", "scientist", "sr", "scientist", "\u2013", "process", "development", "characterization", "join", "protein", "production", "team", "contribute", "development", "protein-based", "vaccines", "prevention", "treatment", "infectious", "diseases", "significant", "impacts", "human", "health", "read", "seeking", "senior", "associate", "join", "analytical", "development", "formulations", "department", "cambridge", "ideal", "candidate", "motivated", "energetic", "detail-oriented", "person", "provide", "support", "analytical", "characterization", "formulation", "development", "protein", "antigens", "used", "vaccines"], "5": ["chip", "clark", "ceo", "genocea", "biosciences", "hesitate", "asked", "give", "top-line", "scientific", "assessment", "company", "mid-stage", "trial", "results", "herpes", "vaccine"], "6": ["tmftypeoh", "jul", "5:17", "pm", "shares", "genocea", "biosciences", "nasdaq", "gnca", "biotech", "company", "focus", "vaccines", "immunotherapies", "fell", "today", "moderating", "back", "loss", "company", "announced", "pricing", "recently", "announced", "million", "public", "offering", "genocea", "selling", "3.85", "million", "shares", "common", "stock", "price", "per", "share", "plus", "granting", "underwriters", "option", "purchase", "additional", "577,500", "shares", "price"], "7": ["company", "overview", "genocea", "biosciences", "inc", "biopharmaceutical", "company", "discovers", "develops", "novel", "vaccines", "immunotherapies", "treat", "infectious", "diseases", "announces", "unaudited", "consolidated", "earnings", "results", "second", "quarter", "six", "months", "june", "genocea", "biosciences", "inc", "announced", "unaudited", "consolidated", "earnings", "results", "second", "quarter", "six", "months", "june", "quarter", "company", "reported", "grant", "revenue", "115,000", "loss", "operations", "10,026", "compared", "6,909", "year", "ago"], "8": ["motley", "fool", "disclosure", "policy", "shares", "genocea", "biosciences", "nasdaq", "gnca", "biotech", "company", "focus", "vaccines", "immunotherapies", "fell", "today", "moderating", "back", "loss", "company", "announced", "pricing", "recently", "announced", "million", "public", "offering", "genocea", "selling", "3.85", "million", "shares", "common", "stock", "price", "per", "share", "plus", "granting", "underwriters", "option", "purchase", "additional", "577,500", "shares", "price"]}